RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. (Q53384430)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 March 2012

Language	Label	Description	Also known as
English	RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.	scientific article published on 10 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Hirozumi Sano

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Akira Shimada

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Tomohiko Taki

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Chisato Murata

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Myoung-Ja Park

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Manabu Sotomatsu

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Ken Tabuchi

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Akio Tawa

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Ryoji Kobayashi

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Keizo Horibe

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Masahiro Tsuchida

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Ryoji Hanada

12

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Ichiro Tsukimoto

13

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Yasuhide Hayashi

14

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

publication date

10 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

95

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

509-515

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Core-binding factors in haematopoiesis and leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Oncogenic K-ras in mouse models of myeloproliferative disease and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Implications of NRAS mutations in AML: a study of 2502 patients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

RAS mutations in pediatric leukemias with MLL gene rearrangements

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1033-X

21 January 2018

Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ras oncogenes in human cancer: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogene activation in human myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of ras gene mutations in childhood myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22407852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-012-1033-X

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22407852

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53384430&oldid=2212099640"